Dextera Surgical to Announce Fiscal 2016 Fourth Quarter Financial Results on Tuesday, August 9, 2016
July 29 2016 - 08:00AM
Dextera Surgical Inc. (Nasdaq:DXTR) today announced that it will
release financial results for its fiscal fourth quarter and full
year ended June 30, 2016, on Tuesday, August 9, 2016, after the
markets close. Dextera Surgical’s management will host a conference
call, which will include a brief presentation and question and
answer session with Joel Dunning, M.D., at 4:30 p.m. Eastern Time
to discuss the financial results and provide an update on the
company’s business. Dr. Dunning is a cardiothoracic surgeon at
James Cook University Hospital, Department of Cardiothoracic
Surgery in Middlesbrough, U.K.
Conference Call DetailsTo access the live
conference call on August 9, 2016, at 4:30 p.m. Eastern Time via
phone, please dial 877-797-0722 from the United States and Canada
or 615-247-0191 internationally. The conference ID is 54847839.
Please dial in approximately 10 minutes prior to the start of the
call. A telephone replay will be available beginning approximately
four hours after the call through August 16, 2016, and may be
accessed by dialing 855-859-2056 from the United States and Canada
or 404-537-3406 internationally. The replay passcode is
54847839.
To access the live and subsequently archived webcast of the
conference call, go to the Investor Relations section of the
company’s website at ir.dexterasurgical.com. Please connect to the
website at least 15 minutes prior to the presentation to allow for
any necessary software downloads.
The webcast is also being distributed through the Thomson
StreetEvents Network. Institutional investors can access the call
via Thomson StreetEvents at www.streetevents.com, a
password-protected event management site.
About Dextera Surgical
Dextera Surgical (Nasdaq:DXTR) designs and manufactures
proprietary stapling devices for minimally invasive surgical
procedures. In the U.S., surgical staplers are routinely used
in more than one million minimally invasive laparoscopic,
video-assisted or robotic-assisted surgical procedures
annually.
The company's signature proprietary technology, the MicroCutter
5/80 Stapler, is the world's first and only five-millimeter
surgical stapler that articulates to 80 degrees in each direction.
As the smallest-profile articulating stapler available today, the
MicroCutter 5/80 Stapler may reduce the amount of dissection and
tissue handling required to position the stapler in confined
spaces, enabling access to difficult-to-reach anatomy. The
cartridge-based device's small size and wide articulation range are
designed to enhance the surgeon's access and visualization at the
surgical site and to mitigate limitations on the advancement of
minimally invasive surgical approaches created by larger stapling
devices.
Dextera Surgical also markets the only automated
anastomosis devices for coronary artery bypass graft (CABG)
surgery on the market today: the C-Port® Distal
Anastomosis Systems and PAS-Port® Proximal Anastomosis
System. These products, sold by Dextera Surgical
under the Cardica brand name, have demonstrated long-term
reliable clinical performance for more than a decade.
Contact:
Bob Newell
Vice President, Finance and Chief Financial Officer
(650) 331-7133
investors@cardica.com
Media:
Kelly Morrison
+1 (224) 240-1481
kelly@kellyamorrison.com